Published in Arthritis Rheum on November 01, 1988
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood (2007) 1.36
Biological significance of soluble IL-2 receptor. Mediators Inflamm (1993) 1.33
Advances in interleukin 2 receptor targeted treatment. Ann Rheum Dis (2000) 1.26
Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol (1993) 1.13
Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis (1991) 1.00
Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency. Clin Exp Immunol (1991) 0.99
Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus. Clin Exp Immunol (1990) 0.96
Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am (2010) 0.94
Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis. PLoS One (2016) 0.89
Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis (1996) 0.88
Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol (2004) 0.84
Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. J Inflamm (Lond) (2009) 0.84
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis. Clin Diagn Lab Immunol (1997) 0.84
Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products. Ann Rheum Dis (1993) 0.84
Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. Clin Exp Immunol (1992) 0.83
Soluble interleukin 2 receptors in patients with polymyositis/dermatomyositis. Ann Rheum Dis (1992) 0.82
Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis. Clin Rheumatol (1998) 0.81
Serum soluble interleukin 2 receptor in systemic lupus erythematosus: effects of disease activity and infection. Ann Rheum Dis (1991) 0.81
Serial measurements of soluble interleukin 2 receptor levels (sIL2-R) in children with juvenile rheumatoid arthritis treated with oral methotrexate. Ann Rheum Dis (1994) 0.80
Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis (1993) 0.80
Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis. Arthritis Res Ther (2009) 0.78
Microheterogeneity of alpha 1 acid glycoprotein in rheumatoid arthritis: dependent on disease duration? Ann Rheum Dis (1993) 0.77
Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Rheumatol (1998) 0.76
Relationship between Serum Level of Interleukin-2 in Patients with Systemic Lupus Erythematosus and Disease Activity in Comparison with Control Group. J Clin Diagn Res (2014) 0.75
Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis. Ann Rheum Dis (1991) 0.75
Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment. Front Microbiol (2016) 0.75
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
Clinical utility of thoracoscopy. Chest (1992) 6.34
Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol (1975) 3.83
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol (2001) 3.63
Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60
Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol (1983) 2.95
Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest (1975) 2.78
Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76
The choroid plexus in systemic lupus erythematosus. Ann Intern Med (1972) 2.69
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60
API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50
Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48
Diverticula of the Small Bowel. Ann Surg (1934) 2.44
Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26
Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med (1972) 2.20
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12
Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12
Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06
Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05
An appraisal of Fc receptors on human peripheral blood B and L lymphocytes. J Immunol (1976) 2.05
Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04
Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97
Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94
Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90
Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum (1972) 1.88
Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87
Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86
Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80
Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest (1980) 1.78
Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med (1989) 1.75
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72
Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69
An analgesia circuit activated by cannabinoids. Nature (1998) 1.68
Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67
Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63
In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60
The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest (1972) 1.60
Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes. J Immunol (1977) 1.57
Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55
Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A (1971) 1.55
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53
Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52
Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol (1974) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis (1984) 1.50
A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med (1975) 1.50
Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother (1981) 1.49
Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest (1988) 1.48
Interaction of vitronectin with Pneumocystis carinii: evidence for binding via the heparin binding domain. J Lab Clin Med (1995) 1.48
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity. Lupus (1999) 1.45
Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44
Recent Trends of Some Infectious Diseases. Br Med J (1942) 1.44
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Simplified method of anaerobic incubation. Appl Microbiol (1971) 1.44
Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44
Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41
Comparison of the Minitek test system with a conventional screening procedure for identification of Enterobacteriaceae. Health Lab Sci (1978) 1.40
Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol (1989) 1.40
Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol (1977) 1.39
Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol (1971) 1.38
Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke (1996) 1.38